Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma

Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect of type I collagen (the predominant comp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2004-11, Vol.10 (21), p.7427-7437
Hauptverfasser: ARMSTRONG, Thomas, PACKHAM, Graham, MURPHY, Lindsay B, BATEMAN, Adrian C, CONTI, John A, FINE, David R, JOHNSON, Colin D, BENYON, R. Christopher, IREDALE, John P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7437
container_issue 21
container_start_page 7427
container_title Clinical cancer research
container_volume 10
creator ARMSTRONG, Thomas
PACKHAM, Graham
MURPHY, Lindsay B
BATEMAN, Adrian C
CONTI, John A
FINE, David R
JOHNSON, Colin D
BENYON, R. Christopher
IREDALE, John P
description Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype. Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures of human PSCs, and type I collagen were investigated in a series of tissue culture models. Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold. Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1 cells in response to 5-fluorouracil (by regulating mcl-1). Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.
doi_str_mv 10.1158/1078-0432.CCR-03-0825
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67061025</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17296509</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</originalsourceid><addsrcrecordid>eNqF0Mtu1DAUgGELUdELPALIG5C6SDk-ju3MsgotVCpihIa15XFOJkFJPNgZob49jmZQl13FUr7jy8_YewE3QqjqswBTFVBKvKnrnwXIAipUr9iFUMoUErV6ndf_zTm7TOk3gCgFlG_YeUayFAgXbLN52hN_4HUYBrejia9jGMNMic8d8e9u6HeTm2a-7mgK82JDy9du8pHc3Hv-5eBnN_DbJv_2Lvp-CqN7y85aNyR6d_pesV_3d5v6W_H44-tDfftYeCWquWgVokYyuJUrAtUqs8VtU6KXFaDxZWNQgjbgvJC-aYTUpZMOpUTTVqtGySv26bjvPoY_B0qzHfvkKb9konBINs9qAfgyFAZXWsEqQ3WEPoaUIrV2H_vRxScrwC7d7dLULk1t7m5B2qV7nvtwOuCwHal5njqFzuDjCbjk3dDGnLBPz06jlpVe3PXRdf2u-9tHsj5LipES5bzdcg8U1pRo5D8KjJfN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17296509</pqid></control><display><type>article</type><title>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Association for Cancer Research</source><source>Alma/SFX Local Collection</source><creator>ARMSTRONG, Thomas ; PACKHAM, Graham ; MURPHY, Lindsay B ; BATEMAN, Adrian C ; CONTI, John A ; FINE, David R ; JOHNSON, Colin D ; BENYON, R. Christopher ; IREDALE, John P</creator><creatorcontrib>ARMSTRONG, Thomas ; PACKHAM, Graham ; MURPHY, Lindsay B ; BATEMAN, Adrian C ; CONTI, John A ; FINE, David R ; JOHNSON, Colin D ; BENYON, R. Christopher ; IREDALE, John P</creatorcontrib><description>Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype. Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures of human PSCs, and type I collagen were investigated in a series of tissue culture models. Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold. Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1 cells in response to 5-fluorouracil (by regulating mcl-1). Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.</description><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-03-0825</identifier><identifier>PMID: 15534120</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Antineoplastic agents ; Apoptosis ; Biological and medical sciences ; Blotting, Western ; Carcinoma, Pancreatic Ductal - metabolism ; Carcinoma, Pancreatic Ductal - pathology ; Cell Line, Tumor ; Cell Proliferation ; Cell Separation ; Collagen - chemistry ; Collagen - metabolism ; Collagen Type I - metabolism ; Collagen Type I - physiology ; Culture Media, Conditioned - pharmacology ; DNA - metabolism ; Dose-Response Relationship, Drug ; Enzyme-Linked Immunosorbent Assay ; Flow Cytometry ; Humans ; Immunohistochemistry ; Medical sciences ; Pancreas - cytology ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; Pharmacology. Drug treatments ; Phenotype ; Reverse Transcriptase Polymerase Chain Reaction ; RNA - metabolism ; Tissue Inhibitor of Metalloproteinase-1 - metabolism ; Tumors</subject><ispartof>Clinical cancer research, 2004-11, Vol.10 (21), p.7427-7437</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</citedby><cites>FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,3357,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16263860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15534120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ARMSTRONG, Thomas</creatorcontrib><creatorcontrib>PACKHAM, Graham</creatorcontrib><creatorcontrib>MURPHY, Lindsay B</creatorcontrib><creatorcontrib>BATEMAN, Adrian C</creatorcontrib><creatorcontrib>CONTI, John A</creatorcontrib><creatorcontrib>FINE, David R</creatorcontrib><creatorcontrib>JOHNSON, Colin D</creatorcontrib><creatorcontrib>BENYON, R. Christopher</creatorcontrib><creatorcontrib>IREDALE, John P</creatorcontrib><title>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><description>Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype. Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures of human PSCs, and type I collagen were investigated in a series of tissue culture models. Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold. Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1 cells in response to 5-fluorouracil (by regulating mcl-1). Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Antineoplastic agents</subject><subject>Apoptosis</subject><subject>Biological and medical sciences</subject><subject>Blotting, Western</subject><subject>Carcinoma, Pancreatic Ductal - metabolism</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cell Separation</subject><subject>Collagen - chemistry</subject><subject>Collagen - metabolism</subject><subject>Collagen Type I - metabolism</subject><subject>Collagen Type I - physiology</subject><subject>Culture Media, Conditioned - pharmacology</subject><subject>DNA - metabolism</subject><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Flow Cytometry</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Medical sciences</subject><subject>Pancreas - cytology</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA - metabolism</subject><subject>Tissue Inhibitor of Metalloproteinase-1 - metabolism</subject><subject>Tumors</subject><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0Mtu1DAUgGELUdELPALIG5C6SDk-ju3MsgotVCpihIa15XFOJkFJPNgZob49jmZQl13FUr7jy8_YewE3QqjqswBTFVBKvKnrnwXIAipUr9iFUMoUErV6ndf_zTm7TOk3gCgFlG_YeUayFAgXbLN52hN_4HUYBrejia9jGMNMic8d8e9u6HeTm2a-7mgK82JDy9du8pHc3Hv-5eBnN_DbJv_2Lvp-CqN7y85aNyR6d_pesV_3d5v6W_H44-tDfftYeCWquWgVokYyuJUrAtUqs8VtU6KXFaDxZWNQgjbgvJC-aYTUpZMOpUTTVqtGySv26bjvPoY_B0qzHfvkKb9konBINs9qAfgyFAZXWsEqQ3WEPoaUIrV2H_vRxScrwC7d7dLULk1t7m5B2qV7nvtwOuCwHal5njqFzuDjCbjk3dDGnLBPz06jlpVe3PXRdf2u-9tHsj5LipES5bzdcg8U1pRo5D8KjJfN</recordid><startdate>20041101</startdate><enddate>20041101</enddate><creator>ARMSTRONG, Thomas</creator><creator>PACKHAM, Graham</creator><creator>MURPHY, Lindsay B</creator><creator>BATEMAN, Adrian C</creator><creator>CONTI, John A</creator><creator>FINE, David R</creator><creator>JOHNSON, Colin D</creator><creator>BENYON, R. Christopher</creator><creator>IREDALE, John P</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20041101</creationdate><title>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</title><author>ARMSTRONG, Thomas ; PACKHAM, Graham ; MURPHY, Lindsay B ; BATEMAN, Adrian C ; CONTI, John A ; FINE, David R ; JOHNSON, Colin D ; BENYON, R. Christopher ; IREDALE, John P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-f52262e72b39e05f57b2bd42c38027c4d7230670ac13cdd1364a3a23327f89d53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Antineoplastic agents</topic><topic>Apoptosis</topic><topic>Biological and medical sciences</topic><topic>Blotting, Western</topic><topic>Carcinoma, Pancreatic Ductal - metabolism</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cell Separation</topic><topic>Collagen - chemistry</topic><topic>Collagen - metabolism</topic><topic>Collagen Type I - metabolism</topic><topic>Collagen Type I - physiology</topic><topic>Culture Media, Conditioned - pharmacology</topic><topic>DNA - metabolism</topic><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Flow Cytometry</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Medical sciences</topic><topic>Pancreas - cytology</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA - metabolism</topic><topic>Tissue Inhibitor of Metalloproteinase-1 - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ARMSTRONG, Thomas</creatorcontrib><creatorcontrib>PACKHAM, Graham</creatorcontrib><creatorcontrib>MURPHY, Lindsay B</creatorcontrib><creatorcontrib>BATEMAN, Adrian C</creatorcontrib><creatorcontrib>CONTI, John A</creatorcontrib><creatorcontrib>FINE, David R</creatorcontrib><creatorcontrib>JOHNSON, Colin D</creatorcontrib><creatorcontrib>BENYON, R. Christopher</creatorcontrib><creatorcontrib>IREDALE, John P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ARMSTRONG, Thomas</au><au>PACKHAM, Graham</au><au>MURPHY, Lindsay B</au><au>BATEMAN, Adrian C</au><au>CONTI, John A</au><au>FINE, David R</au><au>JOHNSON, Colin D</au><au>BENYON, R. Christopher</au><au>IREDALE, John P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2004-11-01</date><risdate>2004</risdate><volume>10</volume><issue>21</issue><spage>7427</spage><epage>7437</epage><pages>7427-7437</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><abstract>Purpose: The purpose of this study was to determine the role of functional interactions between pancreatic cancer cells and pancreatic stellate cells (PSCs) in the formation of the desmoplastic reaction (DR) in pancreatic cancer and to characterize the effect of type I collagen (the predominant component of the DR) on pancreatic cancer cell phenotype. Experimental Design: PSCs and type I collagen were identified in sections of pancreatic cancer using immunohistochemistry, and their anatomic relationship was studied. Interactions among pancreatic cancer cell lines (MIA PaCa-2, Panc-1, and AsPC-1), primary cultures of human PSCs, and type I collagen were investigated in a series of tissue culture models. Results: In vivo , the DR causes gross distortion of normal pancreas, bringing cancer cells into close contact with numerous PSCs and abundant type I collagen. In tissue culture models of pancreatic cancer, conditioned media from each cell line increased PSC [ 3 H]thymidine incorporation up to 6.3-fold that of controls, and AsPC-1 cells also increased PSC collagen synthesis 1.3-fold. Type I collagen was observed to increase long-term survival of pancreatic cancer cells treated with 5-fluorouracil, by up to 62% in clonogenic assays. This was because type I collagen increased the proliferation of cancer cells ([ 3 H]thymidine incorporation was up to 2.8-fold that of cells cultured on tissue culture plastic) and reduced apoptosis of AsPC-1 cells in response to 5-fluorouracil (by regulating mcl-1). Conclusions: These experiments elucidate a mechanism by which the DR in pancreatic cancer may form and, via the collagen within it, promote the malignant phenotype of pancreatic cancer cells, suggesting significant detriment to the host.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15534120</pmid><doi>10.1158/1078-0432.CCR-03-0825</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1078-0432
ispartof Clinical cancer research, 2004-11, Vol.10 (21), p.7427-7437
issn 1078-0432
1557-3265
language eng
recordid cdi_proquest_miscellaneous_67061025
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Association for Cancer Research; Alma/SFX Local Collection
subjects Adenocarcinoma - metabolism
Adenocarcinoma - pathology
Antineoplastic agents
Apoptosis
Biological and medical sciences
Blotting, Western
Carcinoma, Pancreatic Ductal - metabolism
Carcinoma, Pancreatic Ductal - pathology
Cell Line, Tumor
Cell Proliferation
Cell Separation
Collagen - chemistry
Collagen - metabolism
Collagen Type I - metabolism
Collagen Type I - physiology
Culture Media, Conditioned - pharmacology
DNA - metabolism
Dose-Response Relationship, Drug
Enzyme-Linked Immunosorbent Assay
Flow Cytometry
Humans
Immunohistochemistry
Medical sciences
Pancreas - cytology
Pancreatic Neoplasms - metabolism
Pancreatic Neoplasms - pathology
Pharmacology. Drug treatments
Phenotype
Reverse Transcriptase Polymerase Chain Reaction
RNA - metabolism
Tissue Inhibitor of Metalloproteinase-1 - metabolism
Tumors
title Type I Collagen Promotes the Malignant Phenotype of Pancreatic Ductal Adenocarcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T18%3A01%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Type%20I%20Collagen%20Promotes%20the%20Malignant%20Phenotype%20of%20Pancreatic%20Ductal%20Adenocarcinoma&rft.jtitle=Clinical%20cancer%20research&rft.au=ARMSTRONG,%20Thomas&rft.date=2004-11-01&rft.volume=10&rft.issue=21&rft.spage=7427&rft.epage=7437&rft.pages=7427-7437&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-03-0825&rft_dat=%3Cproquest_cross%3E17296509%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17296509&rft_id=info:pmid/15534120&rfr_iscdi=true